Dime Community Bancshares to Release Earnings on January 21, 2026 GlobeNewswire January 13, 2026 HAUPPAUGE, N.Y., Jan. 13, 2026 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company”) today announced that the Company expects to release its earnings for the quarter ended December 31, 2025 before the open of the U.S. equity markets […]

Reflex Advanced Materials Announces Shares for Debt Settlement GlobeNewswire January 13, 2026 VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) — Reflex Advanced Materials Corp. (CSE:RFLX) (OTCQB:RFLXF) (FSE:HF2) (“Reflex” or the “Company”), announces that it has entered into a debt settlement agreement (the “Agreement“) with a service provider of the Company. Pursuant to the Agreement,

Stride Announces Date for Second Quarter Fiscal Year 2026 Earnings Call GlobeNewswire January 13, 2026 RESTON, VA, Jan. 13, 2026 (GLOBE NEWSWIRE) — Stride Inc. (NYSE: LRN) announced today it plans to discuss its second quarter fiscal year 2026 financial results during a conference call scheduled for Tuesday, January 27, 2026 at 5:00 p.m. eastern

BellRing Brands Announces Timing of First Quarter Fiscal Year 2026 Earnings Release and Conference Call GlobeNewswire January 13, 2026 ST. LOUIS, Jan. 13, 2026 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) today announced it will release its financial results for the first quarter of fiscal year 2026 and its fiscal year 2026 outlook on February

(NASDAQ:FFIV), SAN FRANCISCO, Jan. 13, 2026 (GLOBE NEWSWIRE) — A securities class action lawsuit, filed in the wake of an announcement by F5, Inc. (NASDAQ: FFIV) that it experienced a “material cybersecurity incident,” which it discovered on August 9, 2025, seeks to represent investors who purchased F5 securities between October 28, 2024 and October 27,

(NYSE:ADCT), NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its officers and/or

(NYSE:CPNG), SAN FRANCISCO, Jan. 13, 2026 (GLOBE NEWSWIRE) — National shareholder rights firm Hagens Berman is notifying investors in Coupang, Inc. (NYSE: CPNG) that a second securities class action has been filed expanding the Class Period and seeks to represent investors who purchased Coupang securities between May 7, 2025 and December 16, 2025. The Lead

F5, Inc. (FFIV) Cybersecurity Incident-Related Securities Class Action Pending As Adverse Financial Impact Clarified – Hagens Berman FFIV Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire January 13, 2026 SAN FRANCISCO, Jan. 13, 2026 (GLOBE NEWSWIRE) — A securities class action lawsuit, filed in the wake of an announcement by F5, Inc. (NASDAQ: FFIV)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA – ADCT GlobeNewswire January 13, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact

Coupang, Inc. (CPNG) Class Period Expanded in Pending Investor Securities Lawsuit – Hagens Berman CPNG Investors with Losses Encouraged to Contact the Firm GlobeNewswire January 13, 2026 SAN FRANCISCO, Jan. 13, 2026 (GLOBE NEWSWIRE) — National shareholder rights firm Hagens Berman is notifying investors in Coupang, Inc. (NYSE: CPNG) that a second securities class action